News & Articles

Featured Article

Ensuring Safe and Effective Gene Therapy with Precise AAV Capsid Quantification

The delivery systems in gene therapy are primarily classified into two categories: viral vector delivery and non-viral vector delivery. Due to the higher delivery efficiency and stronger tissue specificity, viral vector delivery is, of no doubt, the preferred major approach for gene delivery...

Browse articles by topic:

Ensuring Safe and Effective Gene Therapy with Precise AAV Capsid Quantification

March 25, 2025

6 min read

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

March 5, 2025

4 min read

Effective Serratia marcescens Nuclease for DNA & RNA Removal: MaxNuclease™

February 21, 2025

3 min read

Panorama of CRISPR Gene Editing Clinical Applications: 2024 Review

January 31, 2025

8 min read

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

November 21, 2024

5 min read

2024 Milestones in CRISPR Clinical Pipelines

November 11, 2024

5 min read

AccuBase™ Base Editor Continues to Advance NK Cell Therapies

July 31, 2024

3 min read

IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme

July 24, 2024

4 min read

FDA New Guidelines Pave the Way for Gene Editing Drug Development

April 24, 2024

2 min read

Base Editing Technology Leads a New Chapter in Drug Development

February 14, 2024

5 min read

Exploring RNP: A Cutting-Edge Tool for Gene Delivery

February 2, 2024

5 min read

Empowering Gene Editing Therapy: The Atlas of Gene Editing Enzymes from KACTUS

December 5, 2023

6 min read

1 2

Have questions? Get in touch!

support@kactusbio.us